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Renal Manifestations and Imaging Studies of 
Kawasaki Disease
Purpose: The aim of this study was to verify renal inflammation following Kawasaki 
disease (KD) using single photon emission computed tomography along with 
Technetium-99m dimercaptosuccinic acid scintigraphy (DMSA renal SPECT).
Methods: From March 2011 to October 2011, 15 patients diagnosed with KD at 
the National Health Insurance System Ilsan Hospital were enrolled in the study. 
All patients underwent DMSA renal SPECT to evaluate renal involvement during 
the acute phase of KD. Urine β2-microglobulin (β2-MG), a marker of renal proximal 
tubular dysfunction, was also measured to assess renal damage. 
Results: All 15 patients had normal renal function test results. However, microscopic 
hematuria and pyuria were observed in 13% and 33% of the patients, respectively. 
Moreover, urine β2-MG was elevated in 46% of the patients. In addition, patients 
were divided into two groups based on β2-MG level: those with an increased 
β2-MG level, and those with a normal β2-MG level. No significant differences 
were found between these two groups in clinical characteristics, laboratory, 
sonography, and echocardiography findings. All patients’ DMSA renal SPECT scans 
were normal. 
Conclusion: Our study showed that mild abnormalities in the urinalysis and ele-
vated urine β2-MG were the only findings of renal involvement in KD. However, 
no aggressive renal manifestations were detected on DMSA renal SPECT.
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Introduction
Kawasaki disease (KD) is an acute systemic vasculitis of unknown etio­
logy in children [1]. The most affected age group of KD is younger than 
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five years old [2]. This syndrome is diagnosed based on 
the following clinical criteria: persistent fever for at least five 
days and four of five features­rash, conjunctival injection, 
changes of lips or oral mucosa, erythema and swelling 
of hands and feet, and lymphadenopathy [3, 4]. The 
most common and serious complication is the coronary 
artery dilatation, which peaks at four to six weeks after 
developing KD. However, it is known that if intravenous 
immunoglobulin (IVIG) and high­dosage aspirin were 
administered within 10 days, only 5% of the patients 
were affected by coronary artery complications [5, 6]. 
Genitourinary involvements are rare complications in 
KD. The most common findings are proteinuria and 
sterile pyuria, and microscopic hematuria was observed 
in fewer patients with KD [7, 8]. Although rare, critical 
sequellae, such as interstitial nephritis, hemolytic uremic 
syndrome, nephrotic syndrome, acute renal failure, and 
renovascular hypertension, have been reported [9, 10]. 
However, previous reports about renal involvement 
of KD have been studied by only clinical manifestations 
and laboratory findings, and have not been evaluated 
systematically. Also, to our knowledge, there were only 
a few reports using ultrasonography as an imaging 
modality to confirm renal damage, and only one study 
has been reported from Wang JN, et al. using single 
photon emission computed tomography together with 
Technetium­99m dimercaptosuccinic acid scintigraphy 
(DMSA renal SPECT), highly sensitive and specific 
modality for detecting renal inflammatory scars in 
KD patients. They found that a significantly high ratio 
of the patients who suffered from KD showed renal 
inflammatory foci in DMSA renal SPECT, which suggested 
a possibility of renal scar for mation subsequent to KD [11].
Because of the rarity of the imaging investigations of 
the renal involvement of KD, the patients who were dia­
gnosed KD at our institution went through DMSA renal 
SPECT to confirm the inflammation and scar of the kidney.
Additionally, using urine β2­microgloulin (β2­MG), in­
dicating renal tubular damage marker, we investigated 
origins of proteinuria and the possibility of renal paren­
chymal injury in KD patients.
Materials and methods
1. Patient selection
From March 2011 to October 2011, patients admitted 
to National Health Insurance Service Ilsan Hospital with 
febrile KD were recruited as candidates for this pros­
pective study. KD was defined based on the standard 
diagnostic criteria : persistent fever for at least five days 
and four of five features­rash, conjunctival injection, 
changes of lips or oral mucosa, erythema and swelling 
of hands and feet, and lymphadenopathy [3, 4]. The 
exclusive criteria were history of urinary tract infection, 
positive results from urine culture at initial diagnosis, or 
other urogenital abnormality. The patients who signed 
the informed consent, which was approved by the In­
stitutional review board, were enrolled in the study. 
2. Data collection
All of the patients were initially treated with 2 g/kg of 
IVIG and 100 mg/kg of aspirin orally. When fever was 
subsided, patients were given 5 mg/kg of low­dose 
aspirin. Laboratory and urinalysis data of all patients 
were collected at 1st hospitalization day. Complete 
blood cell counts, C­reactive protein (CRP), and ery­
throcyte sedimentation rate (ESR) were included in 
laboratory data. White blood cell (WBC) count of 4000/
μL to 10,000/μL was considered as a normal range. CRP 
level of over 8 mg/L was considered as a positive for 
inflammation. To evaluate renal function, blood urea 
nitrogen (BUN) and creatinine were measured. Creatinine 
level over 0.4 mg/dL for patients younger than 12 months 
and creatinine level over 0.7 mg/dL for patients older 
than 12 months were considered as having renal pro­
blems. Aspartate aminotransferase (AST) level over 45 
U/L or alanine aminotransferase (ALT) level over 45 U/
L were considered as hepatitis. Hypoalbuminemia was 
considered if albumin level was under 4.0 g/dL. Hypo­
natremia was defined as sodium level below 135 mmol/
L. Also, urine β2­MG, a renal tubular damage marker, 
was considered as presence with renal tubular damage 
if urine β2­MG level was over 0.25 mg/L. Pyuria was 
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diagnosed if urinalysis presented the white blood cell 
count >10 per high power field and hematuria if the red 
blood cell count >5 per high power field.
An ultrasonography (USG) was done to exclude renal 
mass or congenital urogenital anomaly. Also, DMSA renal 
SPECT was done to evaluate renal involvement during 
the acute phase of KD. The images of DMSA renal SPECT 
were officially reviewed by a board­certified nuclear 
medicine doctor. Renal inflammation was diagnosed if 
the image presented either decreased focal uptake or 
diffused diminished DMSA uptake.
Echocardiography was also performed during the acute 
phase of KD by a pediatric cardiologist. If the diameter of 
coronary artery was over 3 mm for patients under 5 years 
old or over 4 mm for patients over 5 years old, those patients 
were diagnosed as having coronary artery dilatation. The 
patients who showed coronary artery dilatation underwent 
follow­up echocardiography after eight weeks.
3. Statistical analysis
Continuous data was analyzed as mean±standard de­
rating, and differences between groups were analyzed 
by Mann­Whitney U test. For <15 cases, categorical data 
was analyzed by Fisher’s exact test with IBM SPSS version 
20.0. (IBM Co., Armonk, NY, USA) for statistics. All values 
with P<0.05 were considered as statistically significant.
Results 
A total of 15 patients were enrolled in this study. The 
study population consisted of 12 boys (80%) and three 
girls (20%). Mean age was 4.5±2.69 years old (range, 2 
to 11 years) at the time of initial diagnosis. From the first 
day of fever development until the first day of admis­
sion, average duration of fever was 6.2 days (range, 5 
to 8 days). Among the 15 patients, fever subsided after 
administering IVIG in 13 (87%) patients. In the remaining 
two patients, fever was subsided in the second admini­
stration of IVIG. None of the patients presented hyper­
tension, oliguria, or polyuria. 
Leukocytosis was observed in 13 patients (87%). Only 
one patient presented leukopenia, and the other one 
stayed in normal range (mean 15,680±7,336/mm3). ESR 
was elevated in all of the patients (48.1±25.2/mm3). 
Thirteen patients (87%) showed an increased CRP level 
(mean 6.6±6.2 mg/L). ALT was elevated in eight (53%) 
patients (mean 85.5±96.0 IU/L). Hypoalbuminemia was 
observed in 14 (93%) patients (mean 3.54±0.45 g/dL), 
and one of them presented marked hypoalbuminemia 
(2.2 mg/dL). There were three patients (19%) who 
showed hyponatremia (mean 135.9±2.9 mmol/L). All 
of the patients presented normal renal function tests. 
In urinalysis, microscopic hematuria and pyuria were 
observed in two patients (13%) and five patients (33%) 
respectively. β2­MG was measured in 13 patients and six 
(46%) of them showed elevated levels (mean 1.40±3.95 
mg/g creatinine). 
Echocardiography showed a coronary artery aneurysm 
in five patients (33%). Only one patient presented remnant 
coronary artery dilatation at the follow­up echocardiography 
performed eight weeks later. The initial USG revealed 
liver or gallbladder abnormality in three patients (20%, 
1 case diffuse liver disease, 1 case mild hepatomegaly, 
1 case distended gallbladder). However, none of the 
patients showed pathologic findings in the kidney. No 
significant findings were observed in DMSA renal SPECT 
in all of the patients (Table 1). 
The patients were divided into two groups with an 
increase in β2­MG levels and with normal range of β2­MG. 
The comparison between the two groups showed no 
significant differences in clinical characteristics, laboratory 
findings, USG, and echocardiography findings (Table 2).
Discussion
KD is known for its systemic involvement in forms of 
vasculitis. Therefore, entire organs are susceptible, and the 
kidney is one of them since it mostly consists of vascular 
structure. Nevertheless, there are only a few reports re­
garding kidney involvement in KD. Most of the studies 
have reported that clinical manifestation of kidney involve­
ment in KD is temporary urethritis or meatitis [12]. However, 
as diagnostic tools have advanced recently, interest has 
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developed for long­term complications and prognosis 
involving the kidney in KD. Even though there were no 
such clinical symptoms in our study, recent case reports 
have presented acute renal failure, hemolytic uremic 
syndrome, and interstitial nephritis as kidney involve­
ment in KD [9, 13, 16].
However, renal involvement in KD patients is mostly 
subclinical pyuria, which makes it very hard to identify 
its origin. To investigate origins of pyuria in KD patients, 
there are reports that support the possibility of KD's 
renal parenchymal involvement by renal biopsy or 
postmortem autopsy. Histological findings have shown 
expansion of mesangial matrix, tubular necrosis, inter­
stitial infiltration of lymphocytes, plasmocytes, and 
eosinophils [10, 14, 17]. In 2007, Watanabe, et al. studied 
the origin of the urinary leukocytes in KD patients with 
Table 1. Clinical Characteristics of Patients with Kawasaki Disease (N=15)
Patient Sex/Age (yrs) Urine β2-MG* (mg/L) Abdominal-sonography DMSA-SPECT Echocardiography
M/7 not checked normal normal normal
M/4 14.50 normal normal coronary dilatation
M/3 0.29 hepatomegaly normal coronary dilatation
M/5 1.06 normal normal normal
M/4 0.95 distended gallbladder normal coronary dilatation
M/2 0.22 normal normal normal
M/4 0.33 normal normal coronary dilatation
M/2 0.06 normal normal normal
M/2 0.05 normal normal normal
M/3 0.39 normal normal normal
M/11 0.22 normal normal normal
M/2 0.11 normal normal coronary dilatation
F/9 not checked diffuse liver disease normal normal
F/6 0.01 normal normal normal
F/4 0.11 normal normal normal
*β2-MG, β2-microglobulin
Table 2. Comparison of Laboratory and Echocardiologic Findings by β2-macroglobulin Levels
β2-microglobulin <0.25 (N=7) (mg/L) ≥0.25 (N=6) (mg/L) P-value
Age (year, mean±SD) 4.14±3.39 3.83±0.75 0.821
Gender                                               0.743
  Male (%) 5 (71.4) 6 (100)
  Female (%) 2 (29.6) 0 (0)
White blood cell count (/μL) 14,657±6,588 19,200±7,468 0.253  
Hemoglobin (g/dL) 11.7±1.5 11.6±0.98 0.775
Albumin (g/dL) 3.7±0.3 3.5±0.64 0.772
Serum BUN (mg/dL) 10.13±4.35 9.8±3.69 0.775
Serum creatinine (mg/dL) 0.34±0.12 0.44±0.09 0.116
AST (IU/L) 60.43±59.7 130.17±53.91 0.153
ALT (IU/L) 75.57±78.18 186.5±105.21 0.617
Na (serum, mmol/L) 135±3.73 136.5±2.43 0.942
ESR (mm/H) 54.29±25.15 52.83±20.61 0.886
CRP (mg/L) 5.31±6.81 8.25±6.41 0.086
Urinalysis
  Pyuria (%)  5 (71.4) 3 (50.0) 0.267
  Hematuria (%) 0 (0) 1 (16.7) 0.462
Echocardiography          0.103
  Normal (%) 6 (85.7) 20 (33.3)
  Abnormal (%) 1 (14.3) 4 (66.7)
Values are mean±standard deviation.
Abbreviations: BUN, blood urea nitrogen; AST, aspartate aminotransferase; ALT, alanine aminotransferase; ESR, erythrocyte sedimentation rate; CRP, 
C-reactive protein 
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pyuria using transcatheterization when collecting urine. 
The study compared voiding urine with urine that was 
obtained by transcatheterization [18]. The results showed 
elevated BUN, creatinine, and β2­MG levels in the group 
with pyuria from the bladder, which was ob tained in 
urine by transcatheterization. From the results, the 
author postulated some patients with KD develop sterile 
pyuria as a result of mild and subclinical renal injury. 
Our study also concluded that pyuria was the most com­
mon form of symptoms (33%). Hematuria was observed 
in two patients (13%). 
Since this study did not use the transcatheterization 
technique to collect urine, we do not know the pyuria 
was due to urethritis or caused by renal injury.  For this 
purpose, β2­MG level, a marker of renal proximal tubular 
damage [19, 20], was compared, but did not show any 
statistically significant difference between the pyuria 
and non­pyuria group. None of them presented with 
elevated BUN and creatinine levels. However, six (46 
%) out of 13 patients showed elevated β2­MG levels, 
which indicates renal parenchymal involvement, such 
as interstitial nephritis. This finding also coincides with 
previous reports[7]. A recent publication reported that 
hyponatremia is related to severe KD [21, 22]. Watanabe et 
al. presented among 114 patients with KD; 51 pati ents 
(44.7%) had hyponatremia, and coronary artery lesions 
and hepatitis were significantly more common in patients 
with hyponatremia. Additionally, pyuria and hematuria 
were present significantly more often in pa tients with 
hyponatremia [23]. However, our study results did not find 
any of significant increase of coronary artery dilatation 
(P=0.242), pyuria (P=0.659), or hematuria (P=0.371) in 
those who presented hyponatremia. 
 Our radiologic study using sonography and DMSA 
renal SPECT also showed differences from previous 
study. According to a study by Nadri et al., four out of 
seven patients presented enlarged, swollen kidneys with 
increased cortico­medullary differentiation in kidney 
USG, which was compatible with renal vasculitis[24]. 
However, regardless of urinalysis results, all 15 patients 
in our study presented normal in kidney USG. 
Recently, Wang et al. reported a study using DMSA 
renal SPECT among KD patients. From this study, the 
author found that 26 out of 50 patients (52%) presented 
kidney parenchymal scarring formation, indicating 
renal involvement of KD[11]. The result of the study 
implicated that long­term follow­up was necessary 
to control possible long­term sequellae, such as renal 
hypertension. On the contrary, none of our patients 
showed abnormalities in DMSA renal SPECT.
There are a few limitations in our study. Due to the 
small number of the study population, selection bias is 
a possibility. Also, there should be long­term follow­ups 
to clarify the course of disease. Finally, catheterization 
of urine collection might increase accuracy of the study. 
In conclusion, our study exhibited that mild abnor­
malities in the urinalysis and elevated β2­MG were the 
only findings of renal involvement in KD. However, there 
were no aggressive renal manifestations detected in DMSA 
renal SPECT.
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한글요약
목적: 본 연구는 가와사키 질환의 신장 침범에 대하여 
비교적 덜 침습적이며, 특이도와 민감도가 높은 검사인 
Technetium­99m dimercaptosuccinic acid scintigraphy 
(DMSA renal SPECT)을 통하여 밝혀보고자 한다.
방법: 2011년 3월부터 10월까지 국민건강보험 일산병
원에서 가와사키로 진단된 15명의 환아들을 대상으로 진
행하였다. 15명의 환아 모두 가와사키의 급성기에 DMSA 
renal SPECT를 시행하였다. 또한 신장 세뇨관 손상 지표인 
요중 β2­microglobulin (β2­MG)을 측정하여 이를 통한 가
와사키 환아에서 신장 손상의 조기 진단 가능 여부를 연구
해보았다.
결과: 환아 15명 모두의 신기능 검사는 정상이었다. 소변 
검사상 현미경적 혈뇨와 농뇨가 각각 13%, 33%에서 관찰
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되었다. 요중 β2­MG는 46%에서 증가된 소견을 보였다. 또
한 환아들을 요중 β2MG를 기준으로 증가되어 있는 군과 
증가되지 않은 군으로 나누어 비교, 분석해 보았으며, 두군
간에 임상 증상, 임상 검사, 초음파 검사 및 심초음파 검사
에서 유의한 차이를 보이지 않았다. 모든 환아에서 DMSA 
renal SPECT는 정상 소견을 보였다.
결론: 본 연구에서 가와사키 질환의 신장 침범은 경한 소
변 검사 이상 및 일부 환아에서의 요중 β2­MG의 상승 소
견을 보였으며, DMSA renal SPECT에서 관찰될 정도의 신
장 침범은 보이지 않았다.
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